Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Namikawa

Showing results (751-760 of 1,022) with videos related to

Pageof 103
Sort By:
Oncotarget|October 21, 2016
Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapyYoshio Nakamura, Shigehisa Kitano, Akira Takahashi, et al.
Cancer Chemotherapy and Pharmacology|September 27, 2015
Phase II study of the immune-checkpoint inhibitor ipilimumab plus dacarbazine in Japanese patients with previously untreated, unresectable or metastatic melanomaN Yamazaki, H Uhara, S Fukushima, et al.
Investigational New Drugs|September 8, 2017
Safety, tolerability, and pharmacokinetic profile of dabrafenib in Japanese patients with BRAF <sup>V600</sup> mutation-positive solid tumors: a phase 1 studyYutaka Fujiwara, Naoya Yamazaki, Yoshio Kiyohara, et al.
Melanoma Research|July 23, 2014
BRAF V600 mutations and pathological features in Japanese melanoma patientsNaoya Yamazaki, Ryota Tanaka, Arata Tsutsumida, et al.
Molecular Biology Reports|October 12, 2012
Branched-chain amino acid-enriched nutrients stimulate antioxidant DNA repair in a rat model of liver injury induced by carbon tetrachlorideKengo Ichikawa, Takehiro Okabayashi, Yasuo Shima, et al.
Gastrointestinal Endoscopy|July 5, 2020
Incidence of metachronous cancer after endoscopic submucosal dissection: a comparison between undifferentiated-type and differentiated-type early gastric cancerMitsuaki Ishioka, Toshiyuki Yoshio, Yuji Miyamoto, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 29, 2024
Incidence and potential risk factors of human cytomegalovirus infection in patients with severe and critical coronavirus disease 2019Waki Imoto, Takumi Imai, Ryota Kawai, et al.
Cancer Science|June 3, 2022
A phase I study of the safety and efficacy of talimogene laherparepvec in Japanese patients with advanced melanomaNaoya Yamazaki, Taiki Isei, Yoshio Kiyohara, et al.
Surgery Today|July 27, 2019
Evolution of photodynamic medicine based on fluorescence image-guided diagnosis using indocyanine green and 5-aminolevulinic acidTsutomu Namikawa, Jun Iwabu, Masaya Munekage, et al.
Archives of Osteoporosis|December 30, 2017
Difference of clinical course between cases with bone union and those with delayed union following osteoporotic vertebral fracturesHiroyuki Yasuda, Masatoshi Hoshino, Tadao Tsujio, et al.
Pageof 103

Showing results (751-760 of 1,022) with videos related to

Sort By:
Pageof 103
Oncotarget|October 21, 2016
Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapyYoshio Nakamura, Shigehisa Kitano, Akira Takahashi, et al.
Cancer Chemotherapy and Pharmacology|September 27, 2015
Phase II study of the immune-checkpoint inhibitor ipilimumab plus dacarbazine in Japanese patients with previously untreated, unresectable or metastatic melanomaN Yamazaki, H Uhara, S Fukushima, et al.
Investigational New Drugs|September 8, 2017
Safety, tolerability, and pharmacokinetic profile of dabrafenib in Japanese patients with BRAF <sup>V600</sup> mutation-positive solid tumors: a phase 1 studyYutaka Fujiwara, Naoya Yamazaki, Yoshio Kiyohara, et al.
Melanoma Research|July 23, 2014
BRAF V600 mutations and pathological features in Japanese melanoma patientsNaoya Yamazaki, Ryota Tanaka, Arata Tsutsumida, et al.
Molecular Biology Reports|October 12, 2012
Branched-chain amino acid-enriched nutrients stimulate antioxidant DNA repair in a rat model of liver injury induced by carbon tetrachlorideKengo Ichikawa, Takehiro Okabayashi, Yasuo Shima, et al.
Gastrointestinal Endoscopy|July 5, 2020
Incidence of metachronous cancer after endoscopic submucosal dissection: a comparison between undifferentiated-type and differentiated-type early gastric cancerMitsuaki Ishioka, Toshiyuki Yoshio, Yuji Miyamoto, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 29, 2024
Incidence and potential risk factors of human cytomegalovirus infection in patients with severe and critical coronavirus disease 2019Waki Imoto, Takumi Imai, Ryota Kawai, et al.
Cancer Science|June 3, 2022
A phase I study of the safety and efficacy of talimogene laherparepvec in Japanese patients with advanced melanomaNaoya Yamazaki, Taiki Isei, Yoshio Kiyohara, et al.
Surgery Today|July 27, 2019
Evolution of photodynamic medicine based on fluorescence image-guided diagnosis using indocyanine green and 5-aminolevulinic acidTsutomu Namikawa, Jun Iwabu, Masaya Munekage, et al.
Archives of Osteoporosis|December 30, 2017
Difference of clinical course between cases with bone union and those with delayed union following osteoporotic vertebral fracturesHiroyuki Yasuda, Masatoshi Hoshino, Tadao Tsujio, et al.
Pageof 103